1.
Besson C. It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies. Haematologica 2022;107(3):572-573; https://doi.org/10.3324/haematol.2021.279457.